Deal Execution And Regulatory RiskThe merger remains subject to shareholder and regulatory approvals, introducing execution and regulatory risk that could delay or prevent expected synergies.
Listing Change And Analyst Coverage RiskTransition to trading under the Coursera name with Nasdaq delisting has prompted analyst No Rating, reducing independent coverage and complicating valuation for former Udemy shareholders.
Subscription Transition And Margin PressureShift from transaction-based consumer sales to subscriptions is expected to depress consumer segment revenue until subscription scale is reached, and incremental product investment may constrain EBITDA margin expansion.